BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

SQURPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

SQURPHARMA 24-Oct-2021

Dividend Declaration (Additional Information): The Company has further informed that the Clarification on increase in EPS are as follows: The growth in our core business i.e. sales of pharmaceutical products has positively affected the EPS for the current year. Moreover, proficient usage of raw materials and optimized utilization of manufacturing overhead while maintaining stringent health and safety measurements to prevent Covid-19 has helped us maintaining a good Cost of Goods Sold for the year. (cont.1)

SQURPHARMA 24-Oct-2021

The Board of Directors has recommended 60% cash dividend for the year ended on June 30, 2021. The Board has also approved Tk. 300.00 crore for BMRE, Capital Machineries and Lands for future expansion. Date of AGM: 15.12.2021, Time: 10:00 AM, Venue: Digital Platform. Record Date: 22.11.2021. (cont.1)

SQURPHARMA 24-Jan-2021

The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2020 to the respective shareholders.

SQURPHARMA 25-Oct-2020

(Continuation news of SQURPHARMA): ii) Bonus share is declared out of accumulated profit. iii) Bonus share is not declared from capital reserve or revaluation reserve or any unrealized gain or out of profit earned prior to incorporation of the Company or through reducing paid up capital or through doing anything so that the post dividend retained earnings become negative or a debit balance. (end)

SQURPHARMA 25-Oct-2020

The Board of Directors has recommended 47% cash and 5% stock dividend for the year ended on June 30, 2020. The Board has also approved Tk. 250.00 crore for BMRE, Capital Machineries and Lands for future expansion. Date of AGM: 15.12.2020, Time: 10:00 AM, Venue: Digital Platform. Record Date: 22.11.2020. (cont.1)

SQURPHARMA 21-Jan-2020

The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2019 to the respective shareholders.

SQURPHARMA 23-Oct-2019

(Continuation news of SQURPHARMA): ii) Bonus share is declared out of accumulated profit. iii) Bonus share is not declared from capital reserve or revaluation reserve or any unrealized gain or out of profit earned prior to incorporation of the Company or through reducing paid up capital or through doing anything so that the post dividend retained earnings become negative or a debit balance. (end)

SQURPHARMA 23-Oct-2019

The Board of Directors has recommended 42% cash and 7% stock dividend for the year ended on June 30, 2019. The Board has also approved Tk. 200.00 crore for BMRE, Capital Machineries and Lands for future expansion. Date of AGM: 12.12.2019, Time: 10:00 AM, Venue: Samson H Chowdhury Centre Dhaka Club Ltd., Ramna, Dhaka. Record Date: 19.11.2019. (cont.1)

SQURPHARMA 28-Jan-2019

The Company has informed that the Cash Dividend for the year ended on June 30, 2018 has been disbursed.

SQURPHARMA 22-Oct-2018

The Board of Directors has recommended 36% cash and 7% stock dividend for the year ended on June 30, 2018. The Board has also approved Tk. 200.00 crore for BMRE, Capital Machinery and Lands for future expansion. Date of AGM: 20.12.2018, Time: 10:00 AM, Venue: Samson H Chowdhury Centre Dhaka Club Ltd., Ramna, Dhaka. Record Date: 27.11.2018. (cont.)

Previous Next page